AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report
AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report
Abstract
Summary
AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
AstraZeneca PLC (AstraZeneca or 'the company') is a manufacturer, developer, and marketer of prescription pharmaceuticals. The company provides drugs for various therapeutic areas, including oncology, cardiovascular, renal and metabolic disease (CVRM), respiratory, inflammation and autoimmunity, infection and vaccines, and neuroscience. AstraZeneca markets its products under Accolate, Casodex, Byetta, Diprivan, Faslodex, Zoladex, Tagrisso, Iressa,Symbicort, Pulmicort, Lynparza, Nexium, and Onglyza brand names. The company sells its products to specialty care and primary care physicians through wholly-owned local marketing companies, local representative offices and distributors. It has business presence across the Americas, Africa, Europe, and Asia. The company is headquarterd in Cambridge, Cambridgeshire, the UK.
Scope
- Detailed information on AstraZeneca PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AstraZeneca PLC in the form of a SWOT analysis
- An in-depth view of the business model of AstraZeneca PLC including a breakdown and examination of key business segments
- Intelligence on AstraZeneca PLC's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AstraZeneca PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of AstraZeneca PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AstraZeneca PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on AstraZeneca PLC's business structure, strategy and prospects.
Content
Table of Contents
Company Snapshot
AstraZeneca PLC: Company Overview
AstraZeneca PLC: Overview and Key Facts
AstraZeneca PLC: Overview
AstraZeneca PLC: Key Facts
AstraZeneca PLC: Key Employees
AstraZeneca PLC: Key Employee Biographies
AstraZeneca PLC: Major Products and Services
AstraZeneca PLC: Company History
AstraZeneca PLC: Management Statement
AstraZeneca PLC: Locations and Subsidiaries
AstraZeneca PLC: Key Competitors
AstraZeneca PLC: Company Analysis
AstraZeneca PLC: Business Description
AstraZeneca PLC: SWOT Analysis
AstraZeneca PLC: SWOT Overview
AstraZeneca PLC: Strengths
AstraZeneca PLC: Weaknesses
AstraZeneca PLC: Opportunities
AstraZeneca PLC: Threats
AstraZeneca PLC: Corporate Financial Deals Activity
AstraZeneca PLC: Financial Deals Overview
AstraZeneca PLC: Targets and Partners
AstraZeneca PLC: Top Deals 2018 - 2022YTD*
AstraZeneca PLC: Advisors
AstraZeneca PLC: Top Legal Advisors
AstraZeneca PLC: Top Financial Advisors
AstraZeneca PLC: Mergers and Acquisitions
AstraZeneca PLC: Corporate Venturing
AstraZeneca PLC: Capital Raising
AstraZeneca PLC: Partnership
AstraZeneca PLC: Divestments
AstraZeneca PLC: Recent Developments
AstraZeneca PLC: News and Events Summary
AstraZeneca PLC: Financial Deals
AstraZeneca PLC: Market Developments
AstraZeneca PLC: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
List Of Tables
Table 1: AstraZeneca PLC: Key Facts
Table 2: AstraZeneca PLC: Key Employees
Table 3: AstraZeneca PLC: Company History
Table 4: AstraZeneca PLC: Locations and Subsidiaries
Table 5: AstraZeneca PLC: Key Competitors
Table 6: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Table 8: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Table 10: AstraZeneca PLC: Targets and Partners
Table 11: AstraZeneca PLC: Top Deals 2018 - 2022YTD*
Table 12: AstraZeneca PLC: Legal Advisor Ranking by Value (US$m)
Table 13: AstraZeneca PLC: Financial Advisor Ranking by Value (US$m)
Table 14: AstraZeneca PLC: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: AstraZeneca PLC: M&A Activity by Geography (2018 - YTD*2022)
Table 16: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 17: AstraZeneca PLC: Corporate Venturing by Geography (2018 - YTD*2022)
Table 18: AstraZeneca PLC: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 19: AstraZeneca PLC: Capital Raising by Deal Type (2018 - YTD*2022)
Table 20: AstraZeneca PLC: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 21: AstraZeneca PLC: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 22: AstraZeneca PLC: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 23: AstraZeneca PLC: Divestments by Geography (2018 - YTD*2022)
Table 24: AstraZeneca PLC: News and Events Summary
Table 25: AstraZeneca PLC: Financial Deals
Table 26: AstraZeneca PLC: Market Developments
Table 27: AstraZeneca PLC: Research & Development
List Of Figures
Figure 1: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Figure 3: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Figure 5: AstraZeneca PLC: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: AstraZeneca PLC: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 8: AstraZeneca PLC: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 9: AstraZeneca PLC: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 10: AstraZeneca PLC: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 11: AstraZeneca PLC: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 12: AstraZeneca PLC: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 13: AstraZeneca PLC: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 14: AstraZeneca PLC: Divestments by Geography (2018 - YTD*2022)
Summary
AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
AstraZeneca PLC (AstraZeneca or 'the company') is a manufacturer, developer, and marketer of prescription pharmaceuticals. The company provides drugs for various therapeutic areas, including oncology, cardiovascular, renal and metabolic disease (CVRM), respiratory, inflammation and autoimmunity, infection and vaccines, and neuroscience. AstraZeneca markets its products under Accolate, Casodex, Byetta, Diprivan, Faslodex, Zoladex, Tagrisso, Iressa,Symbicort, Pulmicort, Lynparza, Nexium, and Onglyza brand names. The company sells its products to specialty care and primary care physicians through wholly-owned local marketing companies, local representative offices and distributors. It has business presence across the Americas, Africa, Europe, and Asia. The company is headquarterd in Cambridge, Cambridgeshire, the UK.
Scope
- Detailed information on AstraZeneca PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AstraZeneca PLC in the form of a SWOT analysis
- An in-depth view of the business model of AstraZeneca PLC including a breakdown and examination of key business segments
- Intelligence on AstraZeneca PLC's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AstraZeneca PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of AstraZeneca PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AstraZeneca PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on AstraZeneca PLC's business structure, strategy and prospects.
Table of Contents
Company Snapshot
AstraZeneca PLC: Company Overview
AstraZeneca PLC: Overview and Key Facts
AstraZeneca PLC: Overview
AstraZeneca PLC: Key Facts
AstraZeneca PLC: Key Employees
AstraZeneca PLC: Key Employee Biographies
AstraZeneca PLC: Major Products and Services
AstraZeneca PLC: Company History
AstraZeneca PLC: Management Statement
AstraZeneca PLC: Locations and Subsidiaries
AstraZeneca PLC: Key Competitors
AstraZeneca PLC: Company Analysis
AstraZeneca PLC: Business Description
AstraZeneca PLC: SWOT Analysis
AstraZeneca PLC: SWOT Overview
AstraZeneca PLC: Strengths
AstraZeneca PLC: Weaknesses
AstraZeneca PLC: Opportunities
AstraZeneca PLC: Threats
AstraZeneca PLC: Corporate Financial Deals Activity
AstraZeneca PLC: Financial Deals Overview
AstraZeneca PLC: Targets and Partners
AstraZeneca PLC: Top Deals 2018 - 2022YTD*
AstraZeneca PLC: Advisors
AstraZeneca PLC: Top Legal Advisors
AstraZeneca PLC: Top Financial Advisors
AstraZeneca PLC: Mergers and Acquisitions
AstraZeneca PLC: Corporate Venturing
AstraZeneca PLC: Capital Raising
AstraZeneca PLC: Partnership
AstraZeneca PLC: Divestments
AstraZeneca PLC: Recent Developments
AstraZeneca PLC: News and Events Summary
AstraZeneca PLC: Financial Deals
AstraZeneca PLC: Market Developments
AstraZeneca PLC: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
List Of Tables
Table 1: AstraZeneca PLC: Key Facts
Table 2: AstraZeneca PLC: Key Employees
Table 3: AstraZeneca PLC: Company History
Table 4: AstraZeneca PLC: Locations and Subsidiaries
Table 5: AstraZeneca PLC: Key Competitors
Table 6: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Table 8: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Table 10: AstraZeneca PLC: Targets and Partners
Table 11: AstraZeneca PLC: Top Deals 2018 - 2022YTD*
Table 12: AstraZeneca PLC: Legal Advisor Ranking by Value (US$m)
Table 13: AstraZeneca PLC: Financial Advisor Ranking by Value (US$m)
Table 14: AstraZeneca PLC: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: AstraZeneca PLC: M&A Activity by Geography (2018 - YTD*2022)
Table 16: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 17: AstraZeneca PLC: Corporate Venturing by Geography (2018 - YTD*2022)
Table 18: AstraZeneca PLC: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 19: AstraZeneca PLC: Capital Raising by Deal Type (2018 - YTD*2022)
Table 20: AstraZeneca PLC: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 21: AstraZeneca PLC: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 22: AstraZeneca PLC: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 23: AstraZeneca PLC: Divestments by Geography (2018 - YTD*2022)
Table 24: AstraZeneca PLC: News and Events Summary
Table 25: AstraZeneca PLC: Financial Deals
Table 26: AstraZeneca PLC: Market Developments
Table 27: AstraZeneca PLC: Research & Development
List Of Figures
Figure 1: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AstraZeneca PLC: M&A Activity by Geography (TTM*)
Figure 3: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
Figure 5: AstraZeneca PLC: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: AstraZeneca PLC: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 8: AstraZeneca PLC: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 9: AstraZeneca PLC: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 10: AstraZeneca PLC: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 11: AstraZeneca PLC: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 12: AstraZeneca PLC: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 13: AstraZeneca PLC: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 14: AstraZeneca PLC: Divestments by Geography (2018 - YTD*2022)
Related Report
